论文部分内容阅读
目的 :探讨黄芪注射液静脉滴注治疗老年心力衰竭的临床疗效。方法 :随机将 64例老年心力衰竭患者分为治疗组和对照组。治疗组用黄芪注射液 40ml(生药 80g)加入 5 %葡萄糖注射液 5 0 0ml静脉滴注 ,每日 1次 ;对照组用硝酸甘油 10mg ,加入 5 %葡萄糖注射液 5 0 0ml静脉滴注 ,每日 1次 ,2周后依据症状、体征及心脏彩超心功能检查判定疗效。结果 :治疗组二周后临床心功能改善显效率及总有效率分别为 62 5 %、90 65 % ,明显优于对照组 (P <0 0 1)。两组治疗后的每搏出量 (SV)、心输出量 (CO)、心脏指数 (CI)、左室射血分数 (LVEF)及左室短轴缩短率 (△D) ,均较治疗前明显改善 ( P <0 0 5 ,P <0 0 1) ,但治疗组更优于对照组( P <0 0 5 )。结论 :黄芪注射液可明显改善老年心力衰竭患者的症状及心功能
Objective: To investigate the clinical effect of intravenous infusion of Astragalus injection in the treatment of heart failure in the elderly. Methods: 64 elderly patients with heart failure were randomly divided into treatment group and control group. Treatment group with astragalus injection 40ml (crude drug 80g) added 5% glucose injection 500ml intravenous infusion, once daily; control group with nitroglycerin 10mg, adding 5% glucose injection 500ml intravenous infusion, each Day 1, 2 weeks after the symptoms, signs and cardiac color Doppler cardiac function test to determine efficacy. Results: Two weeks after treatment, the effective rate of clinical cardiac function improvement and the total effective rate were 62.5% and 90.65% respectively, which was significantly better than that of the control group (P <0.01). The stroke volume (SV), cardiac output (CI), cardiac index (CI), left ventricular ejection fraction (LVEF) and left ventricular fractional shortening (△ D) (P <0.05, P <0.01), but the treatment group was better than the control group (P <0.05). Conclusion: Astragalus injection can significantly improve the symptoms and cardiac function in elderly patients with heart failure